These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22072024)

  • 21. Treatment options for juvenile-onset systemic lupus erythematosus.
    Carreño L; López-Longo FJ; González CM; Monteagudo I
    Paediatr Drugs; 2002; 4(4):241-56. PubMed ID: 11960513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.
    Thorbinson C; Oni L; Smith E; Midgley A; Beresford MW
    Paediatr Drugs; 2016 Jun; 18(3):181-95. PubMed ID: 26971103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic lupus erythematosus exacerbation following cessation of belimumab treatment.
    Furer V; Zisman D; Pokroy-Shapira E; Molad Y; Elkayam O; Paran D
    Scand J Rheumatol; 2016; 45(2):103-6. PubMed ID: 26515057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL,
    Pons-Estel BA; Bonfa E; Soriano ER; Cardiel MH; Izcovich A; Popoff F; Criniti JM; Vásquez G; Massardo L; Duarte M; Barile-Fabris LA; García MA; Amigo MC; Espada G; Catoggio LJ; Sato EI; Levy RA; Acevedo Vásquez EM; Chacón-Díaz R; Galarza-Maldonado CM; Iglesias Gamarra AJ; Molina JF; Neira O; Silva CA; Vargas Peña A; Gómez-Puerta JA; Scolnik M; Pons-Estel GJ; Ugolini-Lopes MR; Savio V; Drenkard C; Alvarellos AJ; Ugarte-Gil MF; Babini A; Cavalcanti A; Cardoso Linhares FA; Haye Salinas MJ; Fuentes-Silva YJ; Montandon de Oliveira E Silva AC; Eraso Garnica RM; Herrera Uribe S; Gómez-Martín D; Robaina Sevrini R; Quintana RM; Gordon S; Fragoso-Loyo H; Rosario V; Saurit V; Appenzeller S; Dos Reis Neto ET; Cieza J; González Naranjo LA; González Bello YC; Collado MV; Sarano J; Retamozo S; Sattler ME; Gamboa-Cárdenas RV; Cairoli E; Conti SM; Amezcua-Guerra LM; Silveira LH; Borba EF; Pera MA; Alba Moreyra PB; Arturi V; Berbotto GA; Gerling C; Gobbi CA; Gervasoni VL; Scherbarth HR; Brenol JCT; Cavalcanti F; Costallat LTL; Da Silva NA; Monticielo OA; Seguro LPC; Xavier RM; Llanos C; Montúfar Guardado RA; Garcia de la Torre I; Pineda C; Portela Hernández M; Danza A; Guibert-Toledano M; Reyes GL; Acosta Colman MI; Aquino AM; Mora-Trujillo CS; Muñoz-Louis R; García Valladares I; Orozco MC; Burgos PI; Betancur GV; Alarcón GS;
    Ann Rheum Dis; 2018 Nov; 77(11):1549-1557. PubMed ID: 30045853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic lupus erythematosus: review of synthetic drugs.
    Tsang-A-Sjoe MW; Bultink IE
    Expert Opin Pharmacother; 2015; 16(18):2793-806. PubMed ID: 26479437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on cyclophosphamide for systemic lupus erythematosus.
    Ortmann RA; Klippel JH
    Rheum Dis Clin North Am; 2000 May; 26(2):363-75, vii. PubMed ID: 10768217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.
    Mok CC; Tse SM; Chan KL; Ho LY
    Lupus; 2018 Apr; 27(5):722-727. PubMed ID: 29087260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of off-label biologicals in systemic lupus erythematosus.
    Aringer M; Smolen JS
    Expert Opin Drug Saf; 2015 Feb; 14(2):243-51. PubMed ID: 25483011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. State-of-the-art treatment of systemic lupus erythematosus.
    Tanaka Y
    Int J Rheum Dis; 2020 Apr; 23(4):465-471. PubMed ID: 32134201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biologics in SLE].
    Karonitsch T; Aringer M
    Wien Med Wochenschr; 2015 Jan; 165(1-2):40-5. PubMed ID: 25411010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus: a case report.
    Danve A; Perry L; Deodhar A
    Semin Arthritis Rheum; 2014 Oct; 44(2):195-7. PubMed ID: 25005336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biologics therapy for systemic lupus erythematosus. Current situation].
    Hoyer BF; Dörner T
    Z Rheumatol; 2015 Apr; 74(3):206-14. PubMed ID: 25854155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
    Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
    J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upcoming biological therapies in systemic lupus erythematosus.
    Sciascia S; Talavera-Garcia E; Roccatello D; Baldovino S; Mengatti E; Cuadrado MJ
    Int Immunopharmacol; 2015 Aug; 27(2):189-93. PubMed ID: 26028152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
    Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
    Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the treatment of systemic lupus erythematosus: From back to the future, to the future and beyond.
    Felten R; Scher F; Sibilia J; Chasset F; Arnaud L
    Joint Bone Spine; 2019 Jul; 86(4):429-436. PubMed ID: 30243784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current role of rituximab in systemic lupus erythematosus.
    Mok CC
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Revision of the recommendations of the Commission on Pharmacotherapy of the German Society for Rheumatology. Comment on the use of mycophenolic acid for systemic lupus erythematosus].
    Fischer-Betz R; Hiepe F;
    Z Rheumatol; 2007 Feb; 66(1):78-82. PubMed ID: 17216418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lupus nephritis: an update.
    Imran TF; Yick F; Verma S; Estiverne C; Ogbonnaya-Odor C; Thiruvarudsothy S; Reddi AS; Kothari N
    Clin Exp Nephrol; 2016 Feb; 20(1):1-13. PubMed ID: 26471017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.